2013 annual financial data

Alnylam Pharmaceuticals 2013 Financial results

Direct answer

Revenue was 47.17M USD.

Operating income was -92.94M USD and net income was -89.23M USD.
Operating cash flow was -68.66M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
47.17M USD
Operating income
-92.94M USD
Net income
-89.23M USD
Operating cash flow
-68.66M USD